BST1 and mesothelioma: In a cohort of 295 patients with PM and non-mesothelioma tumors, CD157 pleural fluid levels demonstrated a sensitivity of 62.3% and a specificity of 73.93% with a cutoff of 23.66 ng/mL as a diagnostic biomarker for PM [38].